Clinical Trial Update: PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia [NA]

View source ↗

Summary

Clinical trial update for PROMISE II evaluating percutaneous deep vein arterialization in late-stage chronic limb-threatening ischemia; status and results detai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Limb-threatening Ischemia
• Peripheral Artery Disease

Snippet

Sponsor: LimFlow, Inc. | Conditions: Critical Limb Ischemia, Critical Lower Limb Ischemia | NA | Status: UNKNOWN | Results posted: 2024-02-28